Monday, November 19, 2012

Findings Address Key Issue Regarding Delivery Of Mesenchymal Stem Cells To Repair Damaged Tissues

Mesenchymal stem cells (MSCs), are a newly emerging cellular therapy being tested in approximately 250 clinical trials worldwide to help repair damaged tissues, such as injured heart muscle following a heart attack. The problem is that when culture-expanded MSCs are injected into the circulation, they have trouble gaining access to the inflamed tissues - exactly where their help is needed...

via Medical News Today

No comments:

Post a Comment